PRKN and Parkinson disease: A study has found that circulating mitochondrial DNA (mtDNA) and interleukin-6 (IL-6) levels in PD patients with Parkin or PINK1 gene mutations are significantly increased, and IL-6 is considered to play a very critical role in the development of PD (Sliter et al., 2018).